Skip to main content
Premium Trial:

Request an Annual Quote

BioCat to Distribute SwitchGear System in Europe

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – SwitchGear Genomics today said that Heidelberg, Germany-based BioCat will distribute the firm's LightSwitch Luciferase Assay System in Europe.

Specifically, the deal covers Germany, Austria, and Switzerland, with full sales, marketing, and technical support from Menlo Park, Calif.-based SwitchGear. Further terms of the agreement were not disclosed.

The LightSwitch system includes a genome-wide collection of human promoter and 3' UTR luciferase reporters and translational efficiency in living cells.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.